Marshall Wace’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8M | Buy |
+242,779
| New | +$11.8M | 0.01% | 710 |
|
|
2023
Q3 | – | Sell |
-4,466
| Closed | -$101K | – | 1894 |
|
|
2023
Q2 | $101K | Buy |
4,466
+3,053
| +216% | +$69K | ﹤0.01% | 1879 |
|
|
2023
Q1 | $35.9K | Buy |
+1,413
| New | +$35.9K | ﹤0.01% | 2050 |
|
|
2022
Q1 | – | Sell |
-7,320
| Closed | -$185K | – | 2682 |
|
|
2021
Q4 | $185K | Sell |
7,320
-1,881
| -20% | -$47.5K | ﹤0.01% | 2502 |
|
|
2021
Q3 | $412K | Buy |
+9,201
| New | +$412K | ﹤0.01% | 1934 |
|
|
2020
Q1 | – | Sell |
-1,980
| Closed | -$152K | – | 1643 |
|
|
2019
Q4 | $152K | Buy |
+1,980
| New | +$152K | ﹤0.01% | 1346 |
|